Second-line FOLFOX chemotherapy versus active symp- tom control for advanced biliary tract cancer (ABC-06): a phase 3, open-label, randomised, con- trolled trial - Lamarca, A; Palmer, D H; Wasan, H S (Lancet Oncol, 2021)
et al.